Literature DB >> 29594684

Human Adipose Tissue Stem Cells Promote the Growth of Acute Lymphoblastic Leukemia Cells in NOD/SCID Mice.

Myoung Woo Lee1,2, Yoo Jin Park1,2, Dae Seong Kim1,2, Hyun Jin Park1,2, Hye Lim Jung1, Ji Won Lee1, Ki Woong Sung1, Hong Hoe Koo3,4,5, Keon Hee Yoo6,7,8.   

Abstract

In this study, the effect of adipose tissue stem cells (ASCs) on the growth of acute lymphoblastic leukemia (ALL) cells was examined in an in vivo model. We established ALL cell lines expressing firefly luciferase (ALL/fLuc) by lentiviral infection that were injected intraperitoneally to NOD/SCID mice. The luciferase activities were significantly higher in mice co-injected with 105 ALL/fLuc cells and ASCs than in those injected with ALL/fLuc cells alone. Co-injection of 105 ALL/fLuc cells and ASCs in differing ratios into mice gradually increased the bioluminescence intensity in all groups, and mice co-injected with 1 or 2 × 106 ASCs showed higher bioluminescence intensity than those receiving lower numbers. Interestingly, in the mice injected with 105 or 107 ALL/fLuc cells alone, the formation of tumor masses was not observed for at least five weeks. Moreover, co-injection of 107 ALL/fLuc cells and 5 × 105 ASCs into mice increased the bioluminescence intensity in all groups, and showed significantly higher bioluminescence intensity compared to mice co-injected with human normal fibroblast HS68 cells. Overall, ASCs promote the growth of ALL cells in vivo, suggesting that ASCs negatively influence hematologic malignancy, which should be considered in developing cell therapy using ASCs.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Adipose tissue stem cell; Cell proliferation; Cell therapy; Firefly luciferase

Mesh:

Substances:

Year:  2018        PMID: 29594684     DOI: 10.1007/s12015-018-9806-0

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  42 in total

1.  Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.

Authors:  T Kinnaird; E Stabile; M S Burnett; C W Lee; S Barr; S Fuchs; S E Epstein
Journal:  Circ Res       Date:  2004-01-22       Impact factor: 17.367

2.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

Review 3.  Mesenchymal stem cells as trophic mediators.

Authors:  Arnold I Caplan; James E Dennis
Journal:  J Cell Biochem       Date:  2006-08-01       Impact factor: 4.429

4.  Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro.

Authors:  P Panayiotidis; D Jones; K Ganeshaguru; L Foroni; A V Hoffbrand
Journal:  Br J Haematol       Date:  1996-01       Impact factor: 6.998

5.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

6.  Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1.

Authors:  Y Zhu; Z Sun; Q Han; L Liao; J Wang; C Bian; J Li; X Yan; Y Liu; C Shao; R C Zhao
Journal:  Leukemia       Date:  2009-01-15       Impact factor: 11.528

7.  Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.

Authors:  M Konopleva; S Konoplev; W Hu; A Y Zaritskey; B V Afanasiev; M Andreeff
Journal:  Leukemia       Date:  2002-09       Impact factor: 11.528

8.  Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma.

Authors:  Aarif Y Khakoo; Shibani Pati; Stasia A Anderson; William Reid; Mohamed F Elshal; Ilsa I Rovira; Ahn T Nguyen; Daniela Malide; Christian A Combs; Gentzon Hall; Jianhu Zhang; Mark Raffeld; Terry B Rogers; William Stetler-Stevenson; Joseph A Frank; Marvin Reitz; Toren Finkel
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

9.  Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant.

Authors:  Ningxia Song; Lei Gao; Huiying Qiu; Chongmei Huang; Hui Cheng; Hong Zhou; Shuqing Lv; Li Chen; Jianmin Wang
Journal:  Int J Mol Med       Date:  2015-04-21       Impact factor: 4.101

10.  Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death.

Authors:  Elin Hallan Naderi; Seham Skah; Hege Ugland; Ola Myklebost; Dagny Lise Sandnes; Maria Lyngaas Torgersen; Dag Josefsen; Ellen Ruud; Soheil Naderi; Heidi Kiil Blomhoff
Journal:  Mol Cancer       Date:  2015-01-27       Impact factor: 27.401

View more
  4 in total

1.  Comparative phenotypic characterization of human colostrum and breast milk-derived stem cells.

Authors:  Nasim Goudarzi; Ronak Shabani; Marzieh Ebrahimi; Amir Baghestani; Ehsan Dehdashtian; Gelareh Vahabzadeh; Mansoure Soleimani; Fatemeh Moradi; Majid Katebi
Journal:  Hum Cell       Date:  2020-01-23       Impact factor: 4.374

Review 2.  A Bird's-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers.

Authors:  Benjamin Motais; Sandra Charvátová; Matouš Hrdinka; Michal Šimíček; Tomáš Jelínek; Tereza Ševčíková; Zdeněk Kořístek; Roman Hájek; Juli R Bagó
Journal:  Cancers (Basel)       Date:  2020-05-23       Impact factor: 6.639

Review 3.  Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts.

Authors:  Ezzatollah Fathi; Zohreh Sanaat; Raheleh Farahzadi
Journal:  Blood Res       Date:  2019-09-25

4.  Adipose-derived stromal cells in regulation of hematopoiesis.

Authors:  Jing Zhang; Yunsheng Liu; Wen Yin; Xingbin Hu
Journal:  Cell Mol Biol Lett       Date:  2020-03-05       Impact factor: 5.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.